Wall Street analysts did not think the data showed enough differentiation.

CMS proposes changes to Medicare and Medicaid to cover weight-loss drugs, recognizing obesity as a disease. This could expand ...

TennCare is federally required to cover GLP-1 drugs; of the $118M in the cost increase request, more than $76 million would ...

President Joe Biden’s proposal to have GLP-1 weight-loss drugs such as Ozempic and Mounjaro covered by Medicare and Medicaid ...

Currently, fewer than one in five large employers are covering such prescriptions despite the boom in popularity of expensive GLP-1 drugs to treat weight loss, according to a KFF analysis earlier this ...

A study of 14,000 WeightWatchers participants is the latest to suggest that Ozempic and similar obesity drugs could be ...

The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.

The thyroid medication levothyroxine may be associated with bone loss, according to a study that will be presented at the ...

Whether this proposed rule actually has any impact remains to be seen, especially with a new administration led by Donald ...

The potential health benefits of GLP-1 diabetes and weight loss meds keep piling up: New research shows they may also shield ...

Amgen's phase 2 data disappointed, but its obesity pipeline still holds potential. See why AMGN stock is appealing even ...

Should I tell relatives I'm taking a weight loss drug? That’s up to you. Eating habits are on display with Thanksgiving meal.